Download Treating Behavioral Problems in Patients with End Stage Demetia

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Start School Later movement wikipedia , lookup

Alzheimer's disease wikipedia , lookup

Transcript
Medication
management
of Behavioral
Problems in
Patients with
End Stage
Dementia
Clinical Features in Late Stage
Dementia
 Alzheimer's
– Delusions, agitation
 Frontotemporal - Personality changes,
disinhibition, Impulsivity
 Lewy Body – Visual Hallucinations, Falls,
Syncope, Sensitivity to Antipsychotic Meds
 Vascular – Abrupt onset, stepwise,
prominent aphasia, severe depression
Partnership
 Crucial
to form a partnership with family
and caregivers
 Neuropsychiatric Inventory and
Behavioral Pathology for Alzheimer
Disease – standardized measures for
assessing behavioral disturbances
Behaviors – Distress related
 Falls,
wandering, repetitive questions,
physical and verbal aggression, resisting
cares, alterations in sleep, agitation,
delusions, hallucinations
 Educate caregivers that some behaviors
don’t respond to pharmaceuticals :
wandering, rummaging, repetitive
questions, calling out
Environmental Triggers
 Lack
of social interaction
 Sensory overstimulation
 Crowded areas
 Large spaces
 Moves
Assessment
 Copy
of History and Physical
 Labs: CBC with platelets, CMP, UA, B12,
Folate, Vitamin D3, TSH, Free T4
 Patient’s Med List
 History of underlying psychiatric illness
 Social History (abuse)
 Course of dementia
 POOP, PEE PAIN
Questions I ask the caregivers








Course of dementia?
Recent medical/drug changes – exacerbation of
chronic disease
Sleep?
Eat? Weight Loss?
Do they ever say they want to die? Tearful?
Delusions (stealing from them, poisoning them)?
Hallucinations (talking to people not there, visual)?
Worse in the afternoon – Sundowning?
Delirium
 Acute
Onset
 Inattention
 Disorganized thinking or Altered Level of
consciousness
Commonly used Drugs with
Anticholinergic effects which
can increase confusion
 Benadryl
– (tylenol sleep)
 Bladder antispasmodics – oxybutynin
 Tricyclic antidepressants
 SNRIs (cymbalta, effexor xr)
 Paxil!
 Olanzapine (Zyprexa)
 Muscle Relaxants – flexeril
 Lasix
Other drugs which cause
confusion and possibly
delirium in the elderly
 Benzodiazepines!
 Gabapentin
 Lasix
 Parkinson
drugs – sinemet, requip, miralax
 Opiates, other pain meds
 ANY DRUGS
Drugs with and indication for
managing behavioral
disturbances in dementia
 NONE
Categories of Medications
used to treat - all off label
Antidepressants
 Mood stabilizers
 Antipsychotics
 Benzodiazepines
 Cognitive enhancers - Anticholinesterase
inhibitors, Namenda

SIG
 Routine
is usually better than prn
Antidepressants
 SSRIs
– Celexa (Citalopram) up to 20mg
Lexapro – up to 10mg
Zoloft – up to 100mg
NOT – Paxil or Prozac
NOT - Tricyclic's
SNRIs – Remeron start with 15mg, Cymbalta,
Effexor - rarely
Wellbutrin XL – morning dose
Serotonin syndrome
 Potentially
fatal, Begins in hours after new
medication
 Confusion
 Alterations in blood pressure and/or
temperature
 Rapid heart rate
 Shivering
 Twitching
Mood Stabilizers





Depakote – usually sprinkles – up to 500mg
divided BID or TID - not much evidence
?(underlying seizure/bipolar)
Tegretol - some evidence
Levels not accurate in elderly although
required by Medicare, monitor platelets and
LFTs
Lamictal – Fast spreading rash (underlying
seizure/bipolar)
NOT LITHIUM
Black Box Warning
 Elderly
patients with dementia related
psychosis treated with an antipsychotic
drug are at an increased risk of death –
they are not approved for the treatment
of dementia related psychosis
 Three fold greater risk of thrombolytic
complications when used for dementia
related behaviors
Antipsychotics
 Risperdal
– 0.25-2mg (ODT)
 Seroquel – 50-200mg
 Zyprexa – 2.5- 10mg (ODT)
 Abilify,
Geodon, Latuda, Saphris, Fanapt
 Improvement in patients with psychosis
and global neuropsychiatric disturbance
Comparative Risk of
antipsychotics
 Retrospective
study of a large cohort of
elderly veterans with dementia
 Death rate per 100 person – years:
 Haldol - 46
 Zyprexa and Risperdal – 27
 Seroquel – 19
 Am. J Psychiatry 2012; 169:71-9
Cognitive Enhancers









Aricept – up to 23 mg (odt) AM dose
Razadyne ER – Up to 10 mg - AM
Exelon po – UP to 12 mg q day
Exelon patch – up to 13.3 q 24 hours
Namenda 10mg bid
Side effects: nausea, diarrhea, headaches
All have titration schedules
Withdraw – taper as appropriate one at a time
Sudden taper – rebound confusion and agitation
Benzodiazepine equivalents
and half lives- including active
metabolites
 Xanax
0.5mg – 6-26 hours
 Ativan – 0.25 10-20 hours
 Klonipin – 0.25 20-50 hours (.125mg q day)
 Valium – 5mg – 20-100 hours
 Side effects: Falls, increased confusion,
disinhibition
 Use tiny doses – frequently if necessary